H

HUTCHMED

652 employees

HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Cancer
Targeted Therapy
Biopharma
Hematology
Health Care
Oncology
Research and Development
Immunology
Inflammation
Medical
Biopharmaceutical
Innovation

Date founded

2000

Funding rounds raised

Total raised

$100M

from 2 investors over 2 rounds

H

HUTCHMED raised $100M on June 25, 2020

Investors: General Atlantic

H

HUTCHMED raised $7.7M on December 21, 2010

Investors: SoftBank China Capital

FAQ